| Title: |
Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis andin vitrocytokine-stimulated blood eosinophils |
| Authors: |
OGAWA, K; HASHIDA, R; MIYAGAWA, M; KAGAYA, S; SUGITA, Y; MATSUMOTO, K; KATSUNUMA, T; AKASAWA, A; TSUJIMOTO, G; SAITO, H |
| Source: |
Clinical and Experimental Immunology ; volume 131, issue 3, page 436-445 ; ISSN 0009-9104 1365-2249 |
| Publisher Information: |
Oxford University Press (OUP) |
| Publication Year: |
2003 |
| Description: |
Summary Investigation of differentially expressed genes in eosinophils of patients with allergic diseases such as atopic dermatitis (AD) will provide important information for elucidating possible mechanisms of pathology. To identify novel genes that are expressed in AD, we compared gene expression in samples of peripheral blood eosinophils from AD patients and healthy volunteers. RNA was extracted from peripheral blood eosinophils. The expression of various genes, such as those for cytokine receptors, eosinophil activation marker, platelet activating factor (PAF) receptor, eosinophil-specific granular proteins and apoptosis-related genes, was confirmed using real-time reverse transcription–polymerase chain reaction (RT-PCR). Peripheral blood eosinophils of healthy volunteers were also isolated and stimulated for introduction of various cytokines. RNA was extracted and gene expression was monitored. Several genes, such as those for cytokine receptors (granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor α and β chain and interleukin (IL)-3 receptor α chain), CD44 and PAF receptor were expressed at significantly higher levels in AD patients than in healthy volunteers. In addition, the anti-apoptotic genes, bcl-2 and bcl-xL, were expressed at increased levels in AD patients. No single gene expression correlated with clinical markers, such as eosinophil count or IgE levels. Expression of GM-CSF receptor β chain and IL-3 receptor α chain in isolated blood eosinophils of healthy volunteers was stimulated by IL-5, IL-4, interferon (IFN)-γ and GM-CSF. Expression of bcl-2 and bcl-xL was also increased after stimulation with IL-5, IL-4 or IFN-γ. The in vitro enhancement of cytokine-stimulated gene expression correlated well with the enhancement observed in clinical samples of eosinophils, suggesting that cytokines may affect gene expression in vivo in eosinophils of patients with AD. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1046/j.1365-2249.2003.02090.x |
| Availability: |
https://doi.org/10.1046/j.1365-2249.2003.02090.x; https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2249.2003.02090.x; https://academic.oup.com/cei/article-pdf/131/3/436/42141430/j.1365-2249.2003.02090.x.pdf |
| Rights: |
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model |
| Accession Number: |
edsbas.D74FB375 |
| Database: |
BASE |